Abstract
Given that we still do not have an effective vaccine against HIV, the development of novel biomedical methods for preventing HIV transmission remains a top priority in controlling the HIV pandemic.
MeSH terms
-
Administration, Intravaginal
-
Anti-Infective Agents / administration & dosage*
-
Anti-Infective Agents / therapeutic use*
-
Anti-Retroviral Agents / administration & dosage
-
Anti-Retroviral Agents / therapeutic use
-
Clinical Trials as Topic
-
Coitus
-
Female
-
HIV Infections / prevention & control*
-
HIV Infections / transmission*
-
Humans
-
Patient Advocacy
-
Private Sector
-
Public Sector
-
Surface-Active Agents / administration & dosage
-
Surface-Active Agents / therapeutic use
Substances
-
Anti-Infective Agents
-
Anti-Retroviral Agents
-
Surface-Active Agents